Open mobile menu
Melvyn Ansell

Melvyn Ansell

Patent Attorney

Melvyn is a European and Chartered UK Patent Attorney in the chemistry & pharmaceuticals team. Melvyn specialises in helping clients achieve exclusivity in their technical field through the development and execution of patent filing and prosecution strategies at all stages of product development and commercialization.

 

Melvyn excels in drafting patent applications in the chemistry field where he combines his deep understanding of the scientific principles that underpin innovation and his extensive knowledge of patent law. His expertise extends to EPO opposition and appeal proceedings, where he represents clients across a diverse array of technologies.

 

Melvyn has developed technical and professional expertise in various fields, including pharmaceuticals, nutrition, catalysis, polymers, and inorganic chemistry. His commitment to excellence and client satisfaction is unwavering, and he remains informed about the latest developments in patent law and technology to provide the highest quality of service. Melvyn is dedicated to helping clients navigate the complexities of intellectual property to ensure their inventions receive the protection they deserve.

 

Melvyn joined the chemistry & pharmaceuticals team at Secerna LLP in 2024, following seven years at several well-respected UK IP firms.

Contact

Email: mansell@secerna.com

Phone: 01904202900

About Melvyn Ansell

Qualifications

  • MChem (Chemistry)
  • PhD (Chemistry)
  • Chartered UK Patent Attorney
  • European Patent Attorney
  • Representative before the Unified Patent Court

 

Specialist Sectors

 

  • Pharmaceuticals
  • Small molecules
  • Nutraceuticals
  • Catalysis
  • Polymers
  • Inorganic chemistry

 

Areas of special expertise

 

  • Drafting and filing patent applications.
  • World-wide prosecution of patent applications
  • Opposition and appeal proceedings at the EPO
  • Patent filing and prosecution strategy
  • IP due diligence services
  • Freedom to operate, infringement and validity opinions